Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_114e4423ec77cbc8dab9d0a98909704e |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-00 |
filingDate |
2003-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccaadc6a49b80b4d2c4ed742645fa9e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d33cc015c7f44c91c4379150cb80004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_601d8c5ea95584995852b0af515368b0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bca7d1f48f6bd4ed53f2890b0cab5b70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f80e381c999398a0efd50e3a928f05e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_896a8c7332c98e43bd9437d1ad60f15d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9701a514e502cfe2a25b7e7fd8ee4f0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_347abe82d92c49fa098878632a518df6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f679af93935462817945c769ab86e3fb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7188ea0790c7fc1cd8b0355a217545f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4173ad007e663c48253e1ea1ddfcb6e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b79d37651e52217443d75a25b90fafc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_383ea2f6c080e71646ef590bdf3cd5df |
publicationDate |
2004-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2004087726-A1 |
titleOfInvention |
Novel nitrile glycoside useful as a bio-enhancer of drugs and nutrients, process of its isolation from moringa oleifera. |
abstract |
The present invention relates to a novel nitrile glycoside of Formula (I) named NIAZIRIDIN and to analogues and derivatives thereof. The present invention also relates to a process for the isolation of a novel nitrile glycoside of Formula (I) below named NIAZIRIDIN and its derivatives and analogues by bioactivity-guided fractionation from the pods of Moringa oleifera. The present invention particularly relates to the bioenhancing activity of the novel nitrile glycoside of Formula (I) below named NIAZIRIDIN and its derivatives and analogues in enhancing bioactivity of commonly used antibiotics such as rifampicin, tetracycline and ampicillin against Gram (+) and (-) bacteria. The biomolecule also enhances the absorption of drugs, vitamins and nutrients through the gastro-intestinal membrane increasing their bio-availability. Therefore niaziridin can be used in combination therapy with drugs and nutrients resulting in reduced drug associated toxicity, reduced cost and duration of chemotherapy. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10359584-B2 |
priorityDate |
2003-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |